The next-generation tablet against hay fever
in your pharmacy
Fit for throughout the year
Desloranio® – AGAINST HAY FEVER
- Latest generation of antiallergic agents
- Works faster than loratadine 1
- Does not make you sleepy 2
Indication
WHAT IS HAY FEVER?
What is hay fever? Hay fever is an allergy to pollen, i.e., to the pollen of plants. Grass and cereal pollen as well as early flowering trees such as hazel, alder and birch cause allergic reactions most commonly. The main flowering period is in spring and summer. Therefore, this kind of hay fever is called “seasonal”, i.e., the allergic rhinitis which is triggered at the respective pollen season. In contrast, there is also an all-season allergic rhinitis, i.e., the permanent allergic rhinitis which is triggered by house dust mites, animal hair or mould. Many people are affected by hay fever. Almost every fourth to fifth adult suffers from it.
WHAT IS Desloranio®?
Desloranio® is a newer generation antihistamine that helps against hay fever and dust mite allergy. It is one of the so-called 3rd generation antihistamines that does not make you sleepy and is now also available in pharmacies without prescription.
The newer generation of antihistamines with the active ingredient desloratadine makes you less tired, works faster and has fewer side effects than the first generation. Symptoms like sneezing, runny or itchy nose, itchy palate and itchy, red, or watery eyes are now a thing of the past. The improvement in these symptoms can last a whole day and help you resume your normal daily activities.
PRODUCT DETAILS
Desloranio®
Active substance
5 mg Desloratadine
Lactose tolerance
Lactose-free
Indication
Allergic rhinitis (hay fever or pollen allergy, dust mite and pet hair allergy) and urticaria (hives)
Dosage
1 tablet daily
Prices (RRP*)
20 film-coated-tablets (N1): 9,50 euro
50 film-coated-tablets (N2): 20,50 euro
100 film-coated-tablets (N3): 37,50 euro
*Recommended Retal Price xxxx –> (incl. VAT) in Lauer-Taxe, as at: August 2021.
** in German
Mandatory information:
Desloranio® 5 mg Filmtabletten Wirkstoff: Desloratadin. Anwendungsgebiete: Besserung der Symptomatik der allergischen Rhinitis und Urtikaria bei Erwachsenen und Jugendlichen ab 12 Jahren. Warnhinweis: Arzneimittel für Kinder unzugänglich aufbewahren. Apothekenpflichtig. Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihren Arzt oder Apotheker. axunio Pharma GmbH, 22767 Hamburg. Stand der Information: 06/2022
Antihistamine generations
Why does Desloranio® NOT MAKE YOU SLEEPY?
Antihistamines are classified according to H1, H2, H3 and H4 histamine receptors. However, only the H1 receptors are used in the treatment of allergy symptoms such as hay fever^3. Within the H1 antihistamines, there is a subdivision into three generations:
H1 antihistamines of the 1st generation
The H1 antihistamines of the 1st generation pass through the blood-brain barrier and thus, enter the brain, which in turn can lead to side effects such as tiredness, headache, fatigue, dizziness or a dry mouth.
Active ingredients: clemastine, dimetindene and hydroxyzine.
H1 antihistamines of the 2nd generation
By contrast, the H1 antihistamines of the 2nd generation cross the blood-brain barrier only insignificantly and therefore, cause less tiredness and drowsiness.
Active ingredients: Loratadine, cetirizine, terfenadine, levocabastine, azelastine, mizolastine and ebastine.
3rd generation H1 antihistamines
In fact, the 3rd generation is a progression of the 2nd generation differing in faster onset of action, longer duration of effectiveness and no tiredness.
Active ingredients: Desloratadine, Levocetirizine and fexofenadine
Breathing freely
From my own experience I can confirm that it helps quickly against my sneezing attacks and runny nose and does not make me sleepy. In this way I can also enjoy the spring and the summer without any complaints and restrictions.
Lisa Nguyen
Product Manager
1 Bachert, C. et al. Safety and Efficacy of Desloratadine in Subjects with seasonal allergic Rhinitis or chronic urticaria – Results of four Post marketing Surveillance Studies. Clin Drug Investig 2010; 30 (2):109-122
2 Package leaflet Desloranio®, lastly revised: June 2022
3 Pearlman D. S. Pharmacology and Clinical Use. Drugs 2012; 12, 258-273(1976)
